Delegation of China pharmaceutical promotion association visited the US Department of Commerce (a series of reports on visit to the US and Canada 7)

Source: on the afternoon of July 12, 2013, a delegation from China pharmaceutical promotion association, composed of song Ruilin, executive chairman, Chen Changxiong, executive deputy secretary general, and Wang Xin, deputy director of international affairs, visited the Department of Commerce of the United States Craig Allen, assistant deputy secretary of Commerce of the United States, Jeff gren, director of the office of health and consumer products, and other officials received the delegation of China Council for the promotion of drugs Scott Tatlock, deputy director of China Office of the International Trade Bureau of the US Department of Commerce, and Amy Weiner, international trade consultant, attended the meeting The two sides have conducted in-depth and friendly exchanges on the main factors of innovation and development of the pharmaceutical industry, encouraging policies, construction of market environment, improvement of laws and regulations, etc First of all, Craig Allen, on behalf of the US Department of Commerce, extended a warm welcome to the visit of the China Council for the promotion of drugs He said that at present, the relationship between China and the United States is very healthy and friendly, and the pharmaceutical industry of both sides should take this opportunity to carry out more cooperation, and constantly put forward forward forward forward forward forward forward forward forward forward forward forward forward forward forward forward forward forward forward forward forward forward forward and constructive policy suggestions to support the innovation and development of the pharmaceutical industry Song Ruilin, executive chairman, agreed with Craig Allen He pointed out that after many years of unremitting efforts, China's pharmaceutical industry has undergone tremendous changes, paying more attention to the development strategy of globalization China is gradually improving policies to encourage and protect innovation In the context of the China US strategic economic dialogue, both sides should deepen understanding and mutual trust, and constantly make more and more common voices in cooperation At the same time, the U.S side is welcome to participate in the policy research conducted by the China Association for the promotion of drugs and the National Center for drug policy and pharmaceutical industry economics of China Pharmaceutical University Later, director Jeff gren proposed that the two sides could jointly hold training or seminar activities in unsafe drug testing technology, multi center clinical research, API quality supervision, etc President Song said that China has a relatively perfect legal system for the supervision of APIs China Council for the promotion of drugs is willing to cooperate with the US Department of Commerce to participate in policy research activities in the fields of unsafe drug testing technology and multi center clinical research, so as to promote the innovation and development of the global pharmaceutical industry Director Jeff gren proposed that he hoped to strengthen cooperation with the China Council for the promotion of drugs He also made it clear that he would like to have separate exchanges and cooperate with the China Council for the promotion of drugs to carry out relevant policy research at the China US Joint Commission on commerce and trade to be held in Beijing in September this year Delegation of China Council for the promotion of drugs visited the US Department of Commerce Delegation of China Council for the promotion of drugs took photos with experts from the US Department of Commerce (from left: Amy Weiner, Scott Tatlock, Jeff gren, song Ruilin, Chen Changxiong, Wang Xin)